☆ 4.6 Article

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study

Tariq U. Azam et al.

Summary: Racial disparities exist among COVID-19 hospitalized patients, with Black patients having a higher prevalence of risk factors and a greater need for renal replacement therapy and mechanical ventilation. Black patients receive less medication treatment and participate less in clinical trials. Black race is associated with lower levels of inflammatory markers and higher odds of death, mechanical ventilation, and renal replacement therapy. The differences in outcomes become non-significant after adjusting for medication use.

AMERICAN JOURNAL OF MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19

Alexi Vasbinder et al.

Summary: Diabetes mellitus is a major risk factor for severe COVID-19, and the association between diabetes and COVID-19 outcomes may be largely mediated by inflammation as assessed by suPAR levels. Hyperglycemia, independent of inflammation, also plays a role in COVID-19 outcomes.

DIABETES CARE (2022)

Add to Collection

Article Critical Care Medicine

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia

Jean-Louis Vincent et al.

Summary: Infection with SARS-CoV-2 can lead to thromboembolic complications in COVID-19 patients due to the inflammatory response causing endothelial dysfunction. Understanding the pathophysiology of thrombosis is crucial for developing management and prevention strategies. Treatment decisions in COVID-19 patients are still being determined, with ongoing trials to establish the safety and benefits of prolonged thromboprophylaxis after hospital discharge.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Article Hematology

Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort

Mark M. G. Mulder et al.

Summary: This study found that lower average concentrations of fibrinogen over time were associated with the presence of clinical pulmonary thromboembolism in COVID-19 patients in Intensive Care, while D-dimer, CRP, and ferritin did not show significant association. Lower concentrations of fibrinogen over time may indicate the consumption of fibrinogen related to thrombus formation in the pulmonary vessels.

THROMBOSIS JOURNAL (2021)

Add to Collection

Letter Hematology

Plasma P-selectin is an early marker of thromboembolism in COVID-19

Bank G. Fenyves et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Review Respiratory System

COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms

Joan Loo et al.

Summary: Thrombotic events in COVID-19, especially venous thromboemboli, are associated with disease severity and poor clinical outcomes. Distinctive microvascular abnormalities include endothelial inflammation, disruption of intercellular junctions, and microthrombi formation. COVID-19 can lead to immunothrombosis, and a better understanding of the pathobiological mechanisms is crucial for developing new treatments.

THORAX (2021)

Add to Collection

Article Respiratory System

Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis

Boun Kim Tan et al.

Summary: The prevalence of VTE is high in COVID-19 patients, especially in those admitted to the ICU, while the prevalence of ATE is relatively low and further research is needed.

THORAX (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19

Michael Pan et al.

Summary: The study found that the use of ACEi/ARB in hospitalized COVID-19 patients is associated with lower levels of inflammation and a reduced risk of in-hospital outcomes.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Add to Collection

Editorial Material Critical Care Medicine

Vascular mechanisms and manifestations of COVID-19

Marcel Levi et al.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Emergency Medicine

The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism

Samuel J. Elberts et al.

Summary: This study aimed to evaluate the test characteristics of D-dimer for pulmonary embolism (PE) in patients with a concurrent diagnosis of COVID-19. The performance of D-dimer testing for PE was found to be similar between COVID-19-positive and -negative patients, with slightly different results between two different D-dimer assays.

ACADEMIC EMERGENCY MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou et al.

Summary: The SAVE-MORE phase 3 study demonstrated the efficacy of anakinra, an IL-1 alpha/beta inhibitor, in patients with COVID-19 and high serum levels of soluble plasminogen activator receptor, showing significant reduction in clinical deterioration and decreased 28-day mortality.

NATURE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

Salim S. Hayek et al.

Summary: The study found that higher serum OPN levels in COVID-19 patients are associated with increased odds of death and the need for mechanical ventilation, but the association with the need for renal replacement therapy is unclear.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Soluble Urokinase Receptor and Acute Kidney Injury

Salim S. Hayek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Dominic Wichmann et al.

ANNALS OF INTERNAL MEDICINE (2020)

Add to Collection

Article Hematology

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Jecko Thachil et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Add to Collection

Article Critical Care Medicine

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

Sharon E. Fox et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection A Retrospective Cohort Study

Michaela R. Anderson et al.

ANNALS OF INTERNAL MEDICINE (2020)

Add to Collection

Review Pharmacology & Pharmacy

COVID-19 and pneumonia: a role for the uPA/uPAR system

Daniele D. ' Alonzo et al.

DRUG DISCOVERY TODAY (2020)

Add to Collection

Letter Hematology

Re The source of elevated plasma D-dimer levels in COVID-19 infection

Beverley J. Hunt et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Editorial Material Hematology

Coagulation abnormalities and thrombosis in patients with COVID-19

Marcel Levi et al.

LANCET HAEMATOLOGY (2020)

Add to Collection

Review Hematology

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis

Angelo Porfidia et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Article Urology & Nephrology

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI

Tariq U. Azam et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Add to Collection

Letter Critical Care Medicine

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

Nikoletta Rovina et al.

CRITICAL CARE (2020)

Add to Collection

Article Urology & Nephrology

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD

Shengyuan Luo et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease

Eunsil Hahm et al.

NATURE MEDICINE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease

Salim S. Hayek et al.

NATURE MEDICINE (2017)

Add to Collection

Review Cardiac & Cardiovascular Systems

suPAR: A New Biomarker for Cardiovascular Disease?

Gethin W. Hodges et al.

CANADIAN JOURNAL OF CARDIOLOGY (2015)

Add to Collection

Article Medicine, General & Internal

Soluble Urokinase Receptor and Chronic Kidney Disease

Salim S. Hayek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events

Danny J. Eapen et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Add to Collection

Article Pharmacology & Pharmacy

The Urokinase Receptor System, A Key Regulator at the Intersection between Inflammation, Immunity, and Coagulation

Mario Del Rosso et al.

CURRENT PHARMACEUTICAL DESIGN (2011)

Add to Collection

Article Medicine, General & Internal

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.